Re--I thought that I had made it clear in the past about optimal timing for striking licensing agreements with large pharmas. The ideal time to strike is after FDA approved Phase I safety and Phase IIa efficacy studies are completed.--
That's clear but has absolutely NOTHING to do with the only agreement - MTA - NNVC made to date. How is that going? Where does IT stand? Is it now superseded by the above statement which renders it inconsequential? Strange way to do business! Where does that MTA stand now, today, in existence, or not? Waiting for FDA EKC-Cide approval? Who will sponsor EKC-Cide in the trials? NNVC or that unnamed big pharma? If NNVC - we better raise tons more cash.